Myosin light chain kinase inhibitors induce retraction of mature oligodendrocyte processes

María G Thomas1, Tomás A Santa Coloma, Jorge Correale

  • 1IIB Fundación Campomar, IIB FCEyN, University of Buenos Aires and IIBBA-CONICET, Buenos Aires, Argentina.

Neurochemical Research
|January 7, 2003
PubMed

Insights

Myosin II light chain kinase inhibitors ML-7 and ML-9 alter oligodendrocyte cell shape. These findings suggest that myosin IIA is involved in the adhesion of myelinating processes to the substrate.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Mature oligodendrocytes extend numerous myelinating processes essential for nerve insulation.
  • Process outgrowth and spreading rely on force-generating molecular mechanisms.
  • Myosin II, a motor protein, is implicated in cellular shape dynamics.

Purpose of the Study:

  • To investigate the role of myosin II light chain kinase (MLCK) in oligodendrocyte process morphology.
  • To determine the effect of MLCK inhibitors ML-7 and ML-9 on cultured oligodendrocytes.

Main Methods:

  • Primary oligodendrocyte cultures were treated with ML-7 and ML-9.
  • Changes in oligodendrocyte cell shape and process morphology were analyzed.

Main Results:

  • MLCK inhibitors ML-7 and ML-9 induced significant alterations in oligodendrocyte cell shape.
  • Both drugs caused a retraction of high-order myelinating processes.
  • Results suggest that MLC phosphorylation is crucial for process adhesion.

Conclusions:

  • Myosin IIA likely plays a critical role in mediating the adhesion of myelinating processes to the substrate.
  • Inhibition of MLCK affects oligodendrocyte process stability and morphology.

Related Concept Videos

Classification of Skeletal Muscle Relaxants01:28

Classification of Skeletal Muscle Relaxants

Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
Cell Motility through Blebbing01:16

Cell Motility through Blebbing

Blebs are a type of membrane protrusion formed by the internal hydrostatic pressure of the cytoplasm. Blebs are observed in several cell types, including fibroblasts, immune cells, and single-celled organisms like the amoeba. The primary function of blebs is cell locomotion and apoptosis, but they are also found during necrosis and cell division. The life cycle of a bleb comprises an initiation phase followed by the expansion and retraction phases.
Blebbing Through the Matrix
In multicellular...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...